Coherent and exocad Collaborate to Offer Improved Software Innovation for the Dental Industry

Coherent, a leading manufacturer of laser-based technologies, and exocad, a leading CAD/CAM software developer and supplier for dental applications, have announced a collaboration that both companies believe will improve the digital workflow for dental laboratories. Digital platforms are becoming increasingly important for innovative and modern dental practices and laboratories as they seek to provide the Read more about Coherent and exocad Collaborate to Offer Improved Software Innovation for the Dental Industry[…]

MBST Award 2020 · Dr. Kitaev · ArthroMedCenter · Saratow-Moscow

At the 3rd Wetzlar Medical Symposium about MBST magnetic resonance therapy in Wetzlar, the specialist for orthopaedics, surgery and traumatology Dr. Igor Vladimirovich Kitaev from Moscow was honoured with an MBST Award for his research about MBST magnetic resonance therapy in the treatment of degenerative joint diseases and dorsopathy. MBST Award for Dr. Kitaev At the Read more about MBST Award 2020 · Dr. Kitaev · ArthroMedCenter · Saratow-Moscow[…]

QIAGEN releases QIAstat-Dx test kit to the U.S. as first syndromic test for detection of SARS-CoV-2 coronavirus under new FDA Policy

. • QIAstat-Dx syndromic testing system can differentiate novel coronavirus from 20 other respiratory targets • Requires less than one minute for sample preparation and delivers results in about one hour • Adds an important tool for clinicians as part of QIAGEN’s global mobilization to dramatically scale up production of testing supplies for global response Read more about QIAGEN releases QIAstat-Dx test kit to the U.S. as first syndromic test for detection of SARS-CoV-2 coronavirus under new FDA Policy[…]

BOXER-8110AI: Utilizing Service Robots to Prevent the Spread of Disease

AAEON, a leader in IoT and AI edge computing solutions, has worked with customers to successfully deploy the compact BOXER-8110AI to power automated service robots in hotels and other service industries. With the ongoing Coronavirus disease 19 (COVID-19) pandemic, many countries and communities have banned large assemblies and events, and advised citizens to avoid unnecessary Read more about BOXER-8110AI: Utilizing Service Robots to Prevent the Spread of Disease[…]

“Helmholtz makes important contributions to solve the Corona crisis.”

The number of SARS-CoV-2 infections is increasing dramatically from day to day in Germany and worldwide. Researchers at the Helmholtz Centers are working on the development of new active substances, antibody therapies and testing procedures, the deciphering of infection mechanisms and epidemiological questions. In more than 20 research projects – mainly in the Research Field Read more about “Helmholtz makes important contributions to solve the Corona crisis.”[…]

Kuros strengthens orthobiologics patent portfolio

Grant of US patent covering the use of PTH containing matrices for spinal fusion Grant of US patent covering osteoinductive materials made by certain methods Further strengthens Kuros’s position as a leader in the field of orthobiologics Kuros Biosciences (SIX: KURN) today announced that its subsidiary, Kuros Biosurgery AG, has been granted the US patent, Read more about Kuros strengthens orthobiologics patent portfolio[…]

Immatics Announces Business Combination with Arya Sciences Acquisition Corp., Creating a Publicly Listed Leader in TCR-based Immunotherapies

Upon successful completion of the business combination, Immatics will receive up to approximately $148 million of cash held within Arya’s trust account Leading institutional investors commit $104 million of cash through a common stock private investment in public equity (“PIPE”) led by Perceptive Advisors and other top-tier US healthcare investors Immatics shareholders, Arya shareholders and PIPE Read more about Immatics Announces Business Combination with Arya Sciences Acquisition Corp., Creating a Publicly Listed Leader in TCR-based Immunotherapies[…]

Immunic, Inc. Reports Year End 2019 Financial Results and Highlights Recent Achievements

Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company focused on developing best-in-class, oral therapies for the treatment of chronic inflammatory and autoimmune diseases, today announced financial results for the year ended December 31, 2019 and highlighted recent achievements. "In addition to the closing of our stock-for-stock exchange transaction with Vital Therapies, Inc., which provided our Nasdaq Read more about Immunic, Inc. Reports Year End 2019 Financial Results and Highlights Recent Achievements[…]

QIAGEN gains BARDA funding for approval process of QIAstat-Dx test kit for SARS-CoV-2 coronavirus

  First syndromic testing solution to get U.S. agency’s development support in novel coronavirus response QIAstat-Dx Respiratory SARS-CoV-2 Panel test kit will rapidly differentiate novel coronavirus from 21 other pathogens implicated in respiratory syndromes Further expanding QIAGEN’s global mobilization to scale up testing supplies for the COVID-19 response QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) Read more about QIAGEN gains BARDA funding for approval process of QIAstat-Dx test kit for SARS-CoV-2 coronavirus[…]

Meiko at Medica 2019

Hygiene management and infection prevention are becoming increasingly key factors in many areas. And Meiko has spent decades tackling these issues to find the best solutions for our customers. The key priorities in this area are health and safety in the workplace and general safety – for both patients and employees. Our processes have been Read more about Meiko at Medica 2019[…]